.webp)
Wastewater Treatment for Pharmaceutical Industry: How We Stabilised Biological Treatment After COD Problems
Updated: 5 days ago
Overview
Pharmaceutical wastewater can be difficult to treat because its chemical content can change with each production batch. High COD, solvents, drug residues and certain organic compounds may affect the bacteria inside an ETP. When this happens, COD removal may become unstable. This blog explains the problems we faced with wastewater treatment for pharmaceutical industry operations and what we checked to improve biological treatment. We cover COD loading, oxygen, pH, microbial health and other factors that affect treatment. We also explain how a suitable microbial culture can support bacteria when treating difficult pharmaceutical effluent.
Table of Contents
Why Is Pharmaceutical Wastewater Difficult to Treat?
One of the common challenges in pharmaceutical wastewater treatment is the changing nature of the wastewater.
A pharmaceutical plant may produce different medicines, APIs and chemical intermediates. This means industrial pharmaceutical wastewater can contain different pollutants from one production batch to another.
Some wastewater may contain high levels of biodegradable organic matter. Other batches may contain solvents, drug residues or compounds that bacteria cannot easily break down.
This explains why pharmaceutical wastewater is difficult to treat compared with ordinary sewage.
For an overview of the products and treatment stages used for these complex effluents, see our guide to pharma wastewater treatment products and technologies.
COD, or Chemical Oxygen Demand, indicates the amount of oxidisable material in water. High COD pharmaceutical wastewater puts extra pressure on the treatment plant, especially when the COD load rises suddenly.
Toxic organic compounds wastewater can create another problem. Certain compounds can slow bacterial activity, making pharmaceutical wastewater treatment less stable.
Why Was COD Removal Becoming Unstable?
Our first step was to look beyond the final COD reading.
In activated sludge pharmaceutical effluent treatment, bacteria need suitable conditions to stay active. We checked dissolved oxygen, pH, MLSS, sludge settling and changes in incoming COD.
Sudden changes in high COD pharmaceutical wastewater can disturb the microbial population. The same can happen during API wastewater treatment when the effluent contains solvents, active ingredients or chemical intermediates.
Good biological degradation pharmaceutical wastewater treatment depends on keeping the bacteria active while controlling what enters the biological tank.
How to Reduce COD in Pharmaceutical Wastewater
There is no single answer to how to reduce COD in pharmaceutical wastewater.
First, operators need to find the source of the COD. Some COD is biodegradable, so bacteria can break it down. Other compounds may resist biological treatment and require another treatment stage.
For biological treatment for pharmaceutical wastewater, we focused on:
maintaining suitable dissolved oxygen and pH;
checking incoming COD and sudden load changes;
monitoring MLSS and sludge settling;
checking for compounds that may harm bacterial activity.
These checks helped us understand how to reduce COD in pharmaceutical wastewater without making random changes to the ETP.
A pharmaceutical ETP case study also shows how high-COD pharmaceutical wastewater can be stabilised through biological treatment when the treatment approach is matched to the wastewater characteristics.
Biological Treatment Methods for Pharmaceutical Wastewater
Common biological treatment methods for pharmaceutical wastewater include activated sludge, MBBR, SBR and MBR systems.
Each process uses microorganisms to break down biodegradable organic matter.
Understanding how aerobic bioculture works in wastewater treatment can help operators assess how microbial activity supports biological COD removal.
During pharma effluent treatment, these microorganisms consume organic pollutants and convert them into simpler substances and microbial biomass.
But biological degradation pharmaceutical wastewater has limits. Some pharmaceutical compounds are difficult for bacteria to break down. Toxic organic compounds wastewater may also affect the microbial population.
This is why API wastewater treatment may need pretreatment before wastewater reaches the biological stage.
Supporting the Bacteria in the ETP
Once plant conditions were checked, we looked at the microbial population.
BactaServe Pharma contains acclimatised microorganisms intended for pharmaceutical wastewater containing biodegradable solvents, drug intermediates and organic compounds.
A microbial culture cannot correct poor aeration, unsuitable pH or severe toxic loading by itself. These operating conditions must be checked first.
Microbial performance can also be affected by micronutrient deficiency in wastewater treatment, particularly when the main operating conditions appear satisfactory but biological activity remains weak.
This matters when deciding how to treat pharmaceutical wastewater effectively.
A pharmaceutical ETP works through several connected treatment stages. Biological treatment is one part of that process.
What Helped Us Stabilise Biological Treatment?
Instead of reacting only when the outlet COD increased, we started checking changes before wastewater entered the biological tank.
For activated sludge pharmaceutical effluent, this meant watching influent COD, dissolved oxygen, pH, MLSS and sludge behaviour.
This approach helped identify common challenges in pharmaceutical wastewater treatment earlier.
For industrial pharmaceutical wastewater, regular testing is especially useful because wastewater characteristics can change with production.
Where ammonia is also a concern, a pharma ETP case study on ammoniacal nitrogen removal shows how biological treatment can address a separate nutrient-removal challenge.
Where the microbial population needs support, BactaServe Pharma can be considered as part of the biological treatment programme. Its use should be based on the wastewater load and actual plant conditions.
These checks form an important part of biological treatment for pharmaceutical wastewater and pharma effluent treatment.
For other complex industrial effluents, industrial wastewater treatment biocultures are available for different wastewater characteristics and biological treatment requirements.
Conclusion
Stable wastewater treatment for pharmaceutical industry plants starts with understanding what enters the ETP.
Repeated COD failures do not always mean that the biological process itself is unsuitable. The cause may be sudden COD loading, poor oxygen levels, unsuitable pH, toxic compounds or weak microbial activity.
Operators need to check these factors before changing the treatment process.
A pharmaceutical ETP also needs regular monitoring because production changes can affect wastewater quality. This is a practical way to understand how to treat pharmaceutical wastewater effectively and why biological treatment sometimes becomes unstable.
Good wastewater treatment for pharmaceutical industry operations depends on knowing the wastewater and giving the biological system suitable conditions to work.
Frequently Asked Questions
Why is pharmaceutical wastewater difficult to treat?
The answer to why pharmaceutical wastewater is difficult to treat lies mainly in its chemical content. Wastewater may contain high COD, solvents, APIs and compounds that affect bacterial activity.
What does pharmaceutical wastewater treatment involve?
Pharmaceutical wastewater treatment may include physical, chemical and biological stages. The treatment method depends on the pollutants present in the wastewater.
What biological processes are commonly used?
Common biological treatment methods for pharmaceutical wastewater include activated sludge, MBBR, SBR and MBR processes.
Can biological treatment remove all pharmaceutical COD?
No. Some COD is biodegradable, while some pharmaceutical compounds resist biological breakdown. Extra treatment may be required for these pollutants.
What should be checked when COD removal falls?
Check influent COD, dissolved oxygen, pH, MLSS, sludge settling and possible toxic substances. These checks can help find the cause before changes are made to the treatment process.
